Investigational Schizophrenia Medication Research Study

Now Enrolling Adults Ages 18 to 60

Now Enrolling

About this research study

Velocity is conducting a clinical research study for an investigational medication for Schizophrenia.

This study is evaluating the safety and efficacy of an investigational oral drug in participants with Schizophrenia. The clinical research study lasts up to 11 weeks, with multiple visits to the study site. Additionally, there will be assessments done between visits.

Eligible participants...

  • Must be age 18 to 60
  • Must meet diagnostic criteria for schizophrenia or schizoaffective disorder according to the DSM-5 criteria
    • Must have had an onset of the first episode being 2 or more years ago
  • Must be in the nonacute phase of their illness and clinically stable for the past three months
  • Will receive compensation for study-related time
  • Do not need insurance to join this study
  • May be compensated for long distance travel associated with study participation

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Hallandale Beach, Florida • Velocity Clinical Research

911 E Hallandale Beach Blvd, Hallandale Beach, FL 33009
Phone: (954) 455-5757

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy